Delivery Order SPE2DB25D3005-SPE2DB25FQCDM

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $8.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,592.83 firm fixed-price delivery order is for the supply of Zortress 0.25 mg tablet medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $1,005.00, is for the delivery of the pharmaceutical product ZORTRESS 0.5 MG TABLET UD 60S. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency, and has a firm fixed price and an ultimate completion date of June 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4556351812 - ZORTRESS 0.5 MG TABLET UD 60S. The contract, valued at $14,738.90, was awarded on February 23, 2022, with a completion date of February 24, 2022. The contract is a Delivery Order under a Firm Fixed Price arrangement. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,074.60, is for the delivery of Zortress 0.5 mg tablets. The contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $24,661.08, is a delivery order for the pharmaceutical product Zestril 20 mg Tablet 90s. This award is under a larger Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., doing business as AmerisourceBergen, with the DLA Troop Support Medical valued at up to...
This federal contract award, valued at $11,421.17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award is for $11,421.17 from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for Inlyta 5 mg tablets and is a firm fixed-price delivery order with a completion date of February 24, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $3,595.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award, valued at $3,361.06, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award, valued at $60,476.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
  • SPE2DB25D3005
    Indefinite Delivery Contract
  • SPE2DB25D3005-SPE2DB25FQCDM
    Delivery Order

This federal contract award, valued at $8,263.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the pharmaceutical product ZORTRESS 1 MG TABLET UD 60S. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award did not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about any subcontractors.

Generated 5/5/25, 9:58 AM